Regenerative medicine advertising rules differ by state, and a clinic website counts as advertising. Devvista is a software development and growth agency, not a law firm, so this page reports what two state statutes say and where federal guidance sits.
It is not legal advice. Your counsel decides your wording.
The Problem: Your Website Is an Advertisement
Clinic owners often assume advertising means paid ads. A stem cell advertisement can be a landing page, a social post or a Business Profile listing, and regulators and statutes use the word more widely. A web page that describes a treatment, a social post that names it and a Google Business Profile that lists it can all be an advertisement. When a state writes a disclosure rule for advertisements, those pages are the ones a patient reads.
The cause is simple. Marketing sites are written by marketers, clinical statements are written by clinicians, and nobody owns the sentence in between. This page gives that sentence an owner and a checklist.
We read the primary statute text for Florida and Wyoming. We did not read other states to the same standard, so we say nothing here about what they require.
The Federal Baseline That Applies Everywhere
State laws sit on top of federal rules, and they do not replace them. The FDA's consumer alert on regenerative medicine products states that the only stem cell products it has approved are blood-forming cells from umbilical cord blood. (FDA consumer alert, content current as of April 2024). A separate FDA warning, dated May 2026, says the agency has not reviewed or verified the quality, safety, purity or potency of unapproved products from human cells or tissues marketed online (FDA warning).
For a clinic website this has two practical effects. Do not write that a product is FDA approved or cleared unless it is. Be careful with any wording that could be read as approval, such as mentioning facility registration or a clinical trial listing, and ask counsel before using it. We do not describe the FDA status of any PRP, stem cell or exosome product in our copy. Your medical director and counsel do.
How many more consultations could your clinic book?
Plug in your own numbers. This is a worked example, not a promise.
Assumptions, not results: 40 monthly inquiries, 20% booked today, 30% after faster follow-up and a clearer site, and $450 as the value of a booked patient. Replace them with your own numbers.
Florida: What SB 1768 Requires of Advertisements
Florida's SB 1768 took effect on July 1, 2025. It lets a physician perform certain stem cell therapies that the FDA has not approved, under conditions, and it puts a disclosure rule on advertising. We read the enrolled bill text on the Florida Senate site (SB 1768, enrolled). It amends the medical practice act at s. 458.3245 and the osteopathic act at s. 459.0127.
| Topic | What the bill text says |
|---|---|
| Effective date | July 1, 2025. |
| Scope | Therapies within the physician's scope of practice and related to orthopedics, wound care or pain management. |
| Source of cells | Cells retrieved, manufactured and stored in a facility registered and regulated by the FDA, and certified or accredited by listed bodies including the National Marrow Donor Program and the American Association of Tissue Banks. Products must follow current good manufacturing practices. |
| Advertisements | Any advertisement must state: "This physician performs one or more stem cell therapies that have not yet been approved," in type at least as large as the largest type in the advertisement. |
| Consent | A signed consent form before the therapy, stating that the therapy has not yet been approved by the FDA. |
| Penalties | A violation may lead to disciplinary action by the board. Fetal or embryo-derived treatment carries separate third-degree felony provisions. |
The bill text speaks to a physician's advertisements. A clinic with several providers should ask counsel how the notice applies to a shared website, a social account and a Google Business Profile. We build the notice as a page element that can appear above the fold on every treatment page, so it can be changed in one place.
Wyoming: The Stem Cell Freedom Act and Its Advertising Limit
Wyoming's Stem Cell Freedom Act, Enrolled Act 31 (2026), takes effect on July 1, 2026. We read the enrolled act (SF0048). It is narrower than Florida's in one way: it defines stem cell therapy as treatment using a patient's own mesenchymal stem cells. It is stricter in another: the physician must be registered with the state board of medicine.
- Who: a physician licensed by the state board of medicine. The act excludes physician assistants from the definition.
- Registration: the physician must be registered with the board to provide the therapy, and the board must publish a public registry of registered physicians.
- Consent: written informed consent acknowledging the nature of the therapy, that it is not approved by the FDA, the benefits and risks, and the patient's financial responsibility.
- Manufacturing: cells handled under current good manufacturing practice standards, with institutional review board approval or an investigational product.
- Advertising: a person must not perform, advertise or represent that they provide stem cell therapy under the act without complying with it.
For a Wyoming clinic, the safest reading of that last line is that you should not describe a service as offered under the act until the physician is registered and the other conditions are met. Counsel should confirm.
Other States: What We Have Not Verified
Reports from 2024 to 2026 describe stem cell laws in several other states, including Utah and Tennessee, and a vetoed bill in Arizona. We have not read those texts to the standard we hold this page to, so we state nothing about what they require. A page that guesses at legal text is worse than a page that says "check".
If your clinic is in a state not covered here, the process in the next section still works. The difference is that your counsel supplies the rule and we build the page element that carries it. We will add a state to this page only when we have read the statute itself and can link to it.
A Review Process You Can Run Before Anything Goes Live
This is the process we use with clinics so that nobody is guessing at the last minute.
- List every place you advertise. Website pages, Google Business Profile, social accounts, email footers, text templates, printed flyers and directory listings.
- Mark every sentence that describes a treatment. Highlight anything that says what a therapy does, treats or achieves.
- Have the medical director approve or delete each highlighted sentence. The default is delete.
- Ask counsel for the state notice wording and the places it must appear, then place it as one shared element.
- Check the claims against the federal baseline. No FDA approval language for products that lack it, and no registration or inspection described as an endorsement.
- Date the review. Re-run it every six months and whenever a state law changes.
This takes an afternoon for a small site. A clinic that does it once usually finds three or four sentences it would rather not have published. If you want a second pair of eyes on the website side, book a growth audit.
What We Will and Will Not Write for a Regenerative Clinic
We will write location pages, booking copy, consultation descriptions, staff pages, follow-up text messages and email sequences. We will build the notice element your counsel specifies and place it where the statute needs it. We will build the intake and follow-up path in a CRM; see our regenerative medicine marketing page and our CRM development service.
We will not write that a treatment cures or reverses a disease, we will not publish patient results as proof, and we will not describe a product as FDA approved when it is not. We will not claim HIPAA compliance for any tool unless a signed agreement covers it. These limits protect you, and they protect us.
For work on the site itself, our WordPress development team can add the notice element and keep clinical text editable by your medical director.
Measuring Whether the Review Worked
Compliance work has a measure, even though it feels like paperwork. Count the number of treatment sentences on your site that a clinician has approved in writing, and the number that have not. The second number should be zero. Track the date of your last review. Track every place the state notice appears, and check on a phone as well as a desktop, since a notice pushed below a hero image may not satisfy a rule that asks for visible type.
For the business side of the same site, see how website speed and speed to lead change how many inquiries become consultations.